Filing Details
- Accession Number:
- 0001181431-13-000823
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-01-03 14:36:17
- Reporting Period:
- 2013-01-02
- Filing Date:
- 2013-01-03
- Accepted Time:
- 2013-01-03 14:36:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1492426 | Horizon Pharma Inc. | HZNP | Pharmaceutical Preparations (2834) | 272179987 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1230482 | W Jeffrey Sherman | C/O Horizon Pharma, Inc. 520 Lake Cook Road, Suite 520 Deerfield IL 60015 | Evp & Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-01-02 | 16,304 | $2.36 | 55,099 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee stock options (right to buy) | Acquisiton | 2013-01-02 | 51,000 | $0.00 | 51,000 | $2.40 |
Common Stock | Restricted stock units | Acquisiton | 2013-01-02 | 45,000 | $0.00 | 45,000 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
51,000 | 2023-01-01 | No | 4 | A | Direct | |
45,000 | No | 4 | A | Direct |
Footnotes
- Reflects shares of common stock surrendered via open market sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in December 2012, in order to satisfy certain tax withholding obligations.
- Includes 8,195 shares of the Company's common stock acquired pursuant to an employee stock purchase program.
- The shares subject to the option vest and become exercisable in forty-eight equal monthly installments from the vesting commencement date of January 2, 2013.
- Each restricted stock unit represents a contingent right to receive one share of Horizon Pharma, Inc. common stock.
- The restricted stock units vest in four equal annual installments beginning January 2, 2014.